Proteasome Inhibitor class drugs
3 results
Bortezomib (bortezomib)
(BORTEZOMIB)Zydus Lifesciences Limited
Kyprolis (carfilzomib)
(carfilzomib)Onyx Pharmaceuticals, Inc.
Usage: Kyprolis is indicated for adult patients with relapsed or refractory multiple myeloma, specifically those who have undergone one to three prior therapies, used in combination with agents like lenalidomide and dexamethasone, or as a single agent after one or more lines of therapy.
Ninlaro (ixazomib)
(ixazomib)Takeda Pharmaceuticals America, Inc.
Usage: NINLARO is indicated for the treatment of multiple myeloma in combination with lenalidomide and dexamethasone for patients who have received at least one prior therapy. It is not recommended for maintenance treatment or newly diagnosed cases outside controlled clinical trials.